Results 111 to 120 of about 14,384 (192)

Neuromyelitis Optica Spectrum Disorder: A Case Report

Journal of Nepal Medical Association
Neuromyelitis optica spectrum disorder also known as Devic's disease is an autoimmune condition where the body produces antibodies against Aquaporin-4 in the astrocytes.
Prakriti Karki, Sagar Pahari, Nayan Neupane, Kushal Poudel, Nehal Asharaf   +4 more
doaj   +1 more source

Drug‐Induced Liver Injury During Treatment With Tocilizumab: A Case Report of an Atypical Pattern Lesion

Pharmacology Research &Perspectives, Volume 14, Issue 5, October 2026.
ABSTRACT Tocilizumab is an interleukin‐6 (IL‐6) receptor antagonist indicated for various rheumatologic conditions. While hepatotoxicity is a recognized adverse effect, it predominantly manifests as hepatocellular injury. We report a rare case of drug‐induced liver injury (DILI) presenting with a cholestatic pattern and cholangitis features in a 75 ...
Louis‐Edmond Barbaro, Nouha Ben Othman, Delphine Viard, Fanny Rocher, Elliot Ewig, Raja Mroue, Claire Amigues, Alexandre O. Gérard   +7 more
wiley   +1 more source

Serum GFAP and Age Accurately Distinguish AQP4‐IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack

European Journal of Neurology, Volume 33, Issue 10, October 2026.
After a recent NMOSD attack, serum GFAP and age together provide a simple and powerful way to distinguish AQP4‐IgG NMOSD from MOGAD and related disorders. In 240 patients evaluated within 90 days of an attack from a 640‐patient cohort, this combination achieved high diagnostic accuracy (AUC up to 0.95).
Manon Rival, Fabien Rollot, Sabine Laurent‐Chabalier, Romain Casey, Illiasse El Bahi, Guillaume Brocard, Romain Marignier, Sophie Trouillet‐Assant, Sandra Vukusic, Agnès Fromont, David Axel Laplaud, Guillaume Mathey, Elisabeth Maillart, Laure Michel, Aurélie Ruet, Pierre Labauge, Xavier Ayrignac, Hélène Zephir, Jonathan Ciron, Jérôme de Sèze, Arnaud Kwiatkowski, Caroline Papeix, Pierre Branger, Christine Lebrun‐Frenay, Eric Berger, Pierre Clavelou, Olivier Heinzlef, Jean Pelletier, Abdullatif Al‐Khedr, Olivier Casez, Bertrand Bourre, Alain Créange, Thomas David, Laurent Magy, Jean‐Philippe Camdessanche, Inès Doghri, Amélie Dos Santos, Thibault Mura, Hanane Agherbi, Eric Thouvenot, for the OFSEP Group and NOMADMUS Investigators, Nicolas Collongues, Céline Cognet, Mireille Desille‐Dugast, Nathalie Dufay, Mathilde Berthome, Michael Hisbergues, Sylvain Lehmann, Laurence Liang, Céline Loiseau, Julie Marechal, Estelle Nisse, Françoise Durand‐Dubief, François Cotton, Bertrand Audoin, Mikael Cohen, Nicolas Collongues, Romain Deschamps   +57 more
wiley   +1 more source

Complement activation in immune thrombotic thrombocytopenic purpura: Possible amplifier and potential therapeutic opportunity

HemaSphere, Volume 10, Issue 10, October 2026.
Massimo Cugno, Spero R. Cataland, Bernhard Lämmle   +2 more
wiley   +1 more source

Topics of neuromyelitis optica

Japanese Journal of Clinical Immunology, 2014
Neuromyelitis optica (NMO) has been revealed the difference in the pathology of multiple sclerosis since the anti-aquaporin 4 (AQP4) antibody associated with NMO has been found. The clinical epidemiological study has been reviewed, NMO-related patient number in Japan is estimated to be about 4400 people.
openaire   +3 more sources

Aquaporin-4-positive neuromyelitis optica in a male Caucasian patient: A rare demographic presentation

SAGE Open Medical Case Reports
Neuromyelitis optica with a positive aquaporin-4 antibody is a rare autoimmune condition, which has a higher prevalence in females, and disproportionately affects Black and Asian persons with a typical age of first presentation between the ages of 30 and
Monideep Ghosh, Nesta Baxter, Michael Homer-Ward   +2 more
doaj   +1 more source

Update on neuromyelitis optica: natural history and management

Eye and Brain, 2012
Panitha Jindahra1,2, Gordon T Plant1,21The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK; 2St Thomas' Hospital, Westminster Bridge Road, London, UKAbstract: Neuromyelitis optica or Devic disease is an inflammatory ...
Jindahra P, Plant GT
doaj  

Ravulizumab in neuromyelitis optica spectrum disorder: first clinical experience in Chile. [PDF]

Front Immunol
Santibáñez T, Valdés JM, Romero C, Fruns M, Galleguillos L.   +4 more
europepmc   +1 more source

Neuromyelitis optica spectrum disorder overlapping with Sjögren's disease: immunopathological links and therapeutic implications. [PDF]

Front Immunol
Xu W, Xing H, Hou L.
europepmc   +1 more source

Global trends and emerging hotspots in neuromyelitis optica spectrum disorder diagnostic research: A bibliometric analysis. [PDF]

Medicine (Baltimore)
Lei S, Zhang Y, Wang Y.
europepmc   +1 more source